• 1
    Menck HR, Mills PK. The influence of urbanization, age, ethnicity, and income on the early diagnosis of breast carcinoma: opportunity for screening improvement. Cancer 2001;92: 1299304.
  • 2
    Liotta LA, Kohn, EC. The microenvironment of the tumor–host interface. Nature 2001;411: 3759.
  • 3
    Pollard JW. Tumor–stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res 2001;3: 2307.
  • 4
    Van Waes C, Surh DM, Chen Z, Kirby M, Rhim JS, Brager R, Sessions RB, Poore J, Wolf GT, Carey TE. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 1995;55: 543444.
  • 5
    Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000;57: 2540.
  • 6
    Hieken TJ, Farolan M, D'Alessandro S, Velasco JM. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers. Surgery 2001;130: 593601.
  • 7
    Anderson TJ, Alexander FE, Lamb J, Smith A, Forrest AP. Pathology characteristics that optimize outcome prediction of a breast screening trial. Br J Cancer 2000;83: 48792.
  • 8
    Heimann R, Hellman S. Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer 2000;36: 16319.
  • 9
    Clemons M, Danson S, Hamilton T, Goss P. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev 2001;27: 6782.
  • 10
    Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, et al. Molecular portraits of human breast tumors. Nature 2000;406: 74752.
  • 11
    Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24: 22735.
  • 12
    Heimann R, Hellman S. Aging, progression, and phenotype in breast cancer. J Clin Oncol 1999;16: 268692.
  • 13
    Dandachi N, Hauser-Kronberger C, More E, Wiesener B, Hacker GW, Dietze O, Wirl G. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumor progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 2001;193: 1819.
  • 14
    Thomas PA, Kirschmann DA, Cerhan JR, Folberg R, Seftor EA, Sellers TA, Hendrix MJ. Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients. Clin Cancer Res 1999;5: 2698703.
  • 15
    Benaud C, Dickson, RB, Thompson EW. Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res Treat 1998;50: 97116.
  • 16
    Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow SH, Watson P, Eng C. Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumor–microenvironment interactions. Hum Mol Genet 2001;10: 190713.
  • 17
    Walker RA, Dearing SJ, Gallacher B. Relationship of transforming growth factor beta1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer 1994;69: 11605.
  • 18
    Nagai S, Toi M. Interleukin-4 and breast cancer. Breast Cancer 2000;7: 1816.
  • 19
    Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB. The nuclear factor kappa B (NF-kappaB): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci USA 2001;98: 1038691.
  • 20
    Ludes-Meyers JH, Liu Y, Munoz-Medellin D, Hilsenbeck SG, Brown PH. AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene 2001;20: 277180.
  • 21
    Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 2000;161: 13206.
  • 22
    Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH, Murphy LC. Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers. Cancer Res 2000;60: 27969.
  • 23
    Liang P, Pardee AB. Differential display. A general protocol. Mol Biotechnol 1998;10: 2617.
  • 24
    Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM. The histogenesis of giant cell tumor of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol 2001;16: 297307.
  • 25
    Hirose Y, Aldape K, Takahashi M, Berger, MS, Feuerstein BG. Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diagn 2001;3: 627.
  • 26
    Stanta G, Bonin S, Perin R. RNA extraction from formalin-fixed and paraffin-embedded tissues. Methods Mol Biol 1998;86: 236.
  • 27
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162: 1569.
  • 28
    Hoornaert I, Marynen P, Baens M. 1998. CREBL2, a novel transcript from the chromosome 12 region flanked by ETV6 and CDKN1B. Genomics 1998;51: 1547.
  • 29
    Biamonti G, Buvoli M, Bassi MT, Morandi C, Cobianchi F, Riva S. Isolation of an active gene encoding human hnRNP protein A1: evidence for alternative splicing. J Mol Biol 1998;207: 491503.
  • 30
    Jumaa H, Guenet J-L, Nielsen PJ. Regulated expression and RNA processing of transcripts from the Srp20 splicing factor gene during the cell cycle. Mol Cell Biol 1997;17: 311624.
  • 31
    Zahler AM, Neugebauer KM, Stolk JA, Roth MB. Human SR proteins and isolation of a cDNA encoding SRp75. Mol Cell Biol 1993;13: 40238.
  • 32
    Fu X-D, Maniatis T. Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science 1992;256: 5358.
  • 33
    Wiederrecht G, Martin MM, Sigal NH, Siekierka JJ. Isolation of a human cDNA encoding a 25 kDa FK-506 and rapamycin binding protein. Biochem Biophys Res Commun 1992;185: 298303.
  • 34
    Takagaki Y, MacDonald CC, Shenk T, Manley JL. The human 64-kDa polyadenylylation factor contains a ribonucleoprotein-type RNA binding domain and unusual auxiliary motifs. Proc Natl Acad Sci USA 1992;89: 14037.
  • 35
    Giang DK, Cravatt BF. A second mammalian N-myristoyltransferase. J Biol Chem 1998;273: 65958.
  • 36
    Tirone F. The gene PC3 (TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 2001;187: 15565.
  • 37
    Thompson DA, Weigel RJ. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas. Eur J Biochem 1998;252: 16977.
  • 38
    Grundmann U, Nerlich C, Rein T, Lottspeich F, Kupper HA. Isolation of cDNA coding for the placental protein 15 (PP15). Nucleic Acids Res 1988;16: 4721.
  • 39
    Kedra D, Pan HQ, Seroussi E, Fransson I, Guilbaud C, Collins JE, Dunham I, Blennow E, Roe BA, Piehl F, Dumanski JP. Characterization of the human synaptogyrin gene family. Hum Genet 1998;103: 13141.
  • 40
    Ewbank JJ, Barnes TM, Lakowski B, Lussier M, Bussey H, Hekimi S. Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1. Science 1997;275: 9803.
  • 41
    Smedley D, Hamoudi R, Lu YJ, Cooper C, Shipley J. Cloning and mapping of members of the MYM family. Genomics 1999;60: 2447.
  • 42
    MacLeod AR, Talbot K, Smillie LB, Houlker C. Characterization of a cDNA defining a gene family encoding TM30p1, a human fibroblast tropomyosin. J Mol Biol 1987;194: 110.
  • 43
    Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang S-I, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 1998;95: 87038.
  • 44
    Foss RD, Guha-Thakurta N, Conran RM, Gutman P. Effects of fixative and fixation time on the extraction and polymerase chain reaction amplification of RNA from paraffin-embedded tissue. Comparison of two housekeeping gene mRNA controls. Diagn Mol Pathol 1994;3: 14855.
  • 45
    Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat 1995; 154: 820.
  • 46
    Yasui Y, Goto H, Matsui S, Manser E, Lim L, Nagata K, Inagaki M. Protein kinases required for segregation of vimentin filaments in mitotic process. Oncogene 2001;20: 286876.
  • 47
    Akira S, Nishio Y, Inoue M, Wang X-J, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signalling pathway. Cell 1994;77: 6371.
  • 48
    Than GN, Turoczy T, Sumegi B, Than NG, Bellyei S, Bohn H, Szekeres G. Overexpression of placental tissue protein 17b/TIP47 in cervical dysplasias and cervical carcinoma. Anticancer Res 2001;21: 63942.
  • 49
    Craig TL, Denlinger DL. Sequence and transcription patterns of 60S ribosomal protein P0, a diapause-regulated AP endonuclease in the flesh fly, Sarcophaga crassipalpis. Gene 2000;255: 3818.
  • 50
    Mendez-Alvarez S, Rufenacht K, Eggen RI. The oxidative stress-sensitive yap1 null strain of Saccharomyces cerevisiae becomes resistant due to increased carotenoid levels upon the introduction of the Chlamydomonas reinhardtii cDNA, coding for the 60S ribosomal protein L10a. Biochem Biophys Res Commun 2000;267: 9539.
  • 51
    Lund A, Knudsen SM, Vissing H, Clark B, Tommerup N. Assignment of human elongation factor 1alpha genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3. Genomics 1996;36: 35961.
  • 52
    Braud VM, Allan DSJ, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998;391: 7959.
  • 53
    von Mollard FG, Stevens TH. 1998. A human homolog can functionally replace the yeast vesicle-associated SNARE Vti1p in two vesicle transport pathways. J Biol Chem 1998;273: 262430.
  • 54
    Lee P, Kuhl W, Gelbart T, Kamimura T, West C, Beutler E. Homology between a human protein and a protein of the green garden pea. Genomics 1994;21: 3718.
  • 55
    Her C, Kaur GP, Athwal RS, Weinshilboum RM. Human sulfotransferase SULT1C1: cDNA cloning, tissue-specific expression, and chromosomal localization. Genomics 1997;41: 46770.
  • 56
    O'Callaghan CA. Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumor cells. Clin Sci (Colch) 2000;99: 917.
  • 57
    Seth P, Lunetta KL, Bell DW, Gray H, Nasser SM, Rhei E, Kaelin CM, Iglehart DJ, Marks JR, Garber JE, Haber DA, Polyak K. Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer. Cancer Res 2000;60: 685963.
  • 58
    Steinert PM, Kartasova T, Marekov LN. Biochemical evidence that small proline-rich proteins and trichohyalin function in epithelia by modulation of the biomechanical properties of their cornified cell envelopes. J Biol Chem 1998;273: 1175869.
  • 59
    Evers R, Grummt I. Molecular coevolution of mammalian ribosomal gene terminator sequences and the transcription termination factor TTF-1. Proc Natl Acad Sci USA 1995;92: 582731.
  • 60
    Technau U. Brachyury, the blastopore and the evolution of the mesoderm. Bioessays 2001;23: 78894.
  • 61
    Watkins JL, Murphy R, Emtage JLT, Wente SR. The human homologue of Saccharomyces cerevisiae Gle1p is required for poly(A)+ RNA export. Proc Natl Acad Sci USA 1998;95: 677984.
  • 62
    Jurecic R, Belmont JW. Long-distance DD-PCR and cDNA microarrays. Curr Opin Microbiol 2000;3: 31621.
  • 63
    Chaw YF, Crane LE, Lange P, Shapiro R. Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochemistry 1980;19: 552531.
  • 64
    Rajala RV, Radhi JM, Kakkar R, Datla RS, Sharma RK. Increased expression of N-myristoyltransferase in gallbladder carcinomas. Cancer 2000;88: 19929.
  • 65
    Raju RV, Moyana TN, Sharma RK. N-Myristoyltransferase overexpression in human colorectal adenocarcinomas. Exp Cell Res 1997;235: 14554.
  • 66
    Ntwasa M, Aapies S, Schiffmann DA, Gay NJ. Drosophila embryos lacking N-myristoyltransferase have multiple developmental defects. Exp Cell Res 2000;262: 13444.
  • 67
    Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon MJ, Fleming MA, Caron PR, Hsiao K, Navia MA. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12–FK506 complex. Cell 1995;82: 50722.
  • 68
    Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Yoshida M, Emi M, Nakamura Y, Onda M, Yoshida Y, Nishiyama A, Yamamoto T. Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene 1996;12: 70513.
  • 69
    Yoshida Y, Tanaka S, Umemori H, Minowa O, Usui M, Ikematsu N, Hosoda E, Imamura T, Kuno J, Yamashita T, Miyazono K, Noda M, et al. Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 2000;103: 108597.
  • 70
    Kedra D, Pan HQ, Seroussi E, Fransson I, Guilbaud C, Collins JE, Dunham I, Blennow E, Roe BA, Piehl F, Dumanski JP. Characterization of the human synaptogyrin gene family. Hum Genet 1998;103: 13141.
  • 71
    Jonassen T, Proft M, Randez-Gil F, Schultz JR, Marbois BN, Entian K-D, Clarke CF. Yeast Clk-1 homologue (Coq7/Cat5) is a mitochondrial protein in coenzyme Q synthesis. J Biol Chem 1998;273: 33517.
  • 72
    Paschal BM, Gerace L. Identification of NTF2, a cytosolic factor for nuclear import that interacts with nuclear pore complex protein p62. J Cell Biol 1995;129: 92537.
  • 73
    Hay DC, Kemp GD, Dargemont C, Hay RT. Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol Cell Biol 2000;21: 348290.
  • 74
    Smedley D, Hamoudi R, Lu YJ, Cooper C, Shipley J. Cloning and mapping of members of the MYM family. Genomics 1999;60: 2447.
  • 75
    Talian JC, Olmsted JB, Goldman RD. A rapid procedure for preparing fluorescein-labeled specific antibodies from whole antiserum: its use in analyzing cytoskeletal architecture. J Cell Biol 1983;97: 127782.
  • 76
    Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 1998;95: 87038.
  • 77
    Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001;20: 2499513.
  • 78
    Hasebe T, Sasaki S, Imoto S, Ochiai A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol 2001;14: 32537.